Volume 153, Issue 2 p. 357-358
BRIEF COMMUNICATIONS

Effect of growth hormone administration on ICSI outcomes in patients with polycystic ovary syndrome and recurrent implantation failure: A retrospective cross-over study

Salvatore Giovanni Vitale

Salvatore Giovanni Vitale

Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy

Search for more papers by this author
Marco Palumbo

Marco Palumbo

Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy

Search for more papers by this author
Cristina Conde-López

Cristina Conde-López

Molecular Assisted Reproduction and Genetics, MAR&Gen Clinic, Granada, Spain

Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, Granada, Spain

Search for more papers by this author
Nicolas Mendoza

Nicolas Mendoza

Molecular Assisted Reproduction and Genetics, MAR&Gen Clinic, Granada, Spain

Search for more papers by this author
Raquel Mendoza-Tesarik

Raquel Mendoza-Tesarik

Molecular Assisted Reproduction and Genetics, MAR&Gen Clinic, Granada, Spain

Search for more papers by this author
Jan Tesarik

Corresponding Author

Jan Tesarik

Molecular Assisted Reproduction and Genetics, MAR&Gen Clinic, Granada, Spain

Correspondence

Jan Tesarik, Molecular Assisted Reproduction and Genetics, MAR&Gen Clinic, Camino de Ronda 2, 18006, Granada, Spain.

Email: [email protected]

Search for more papers by this author
First published: 18 December 2020
Citations: 3

Synopsis

The administration of growth hormone during ovarian stimulation in women with RIF and PCOS may improve intracytoplasmic sperm injection outcomes.

CONFLICTS OF INTEREST

The authors have no conflicts of interest.